Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 25/7/20181 min de lectura
Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →